Holowesko Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Holowesko Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-729,671	Closed	-$38.2M	–	36
2014 Q2	$38.2M	Sell	729,671 -665,000	-48%	-$34M	2.31%	21
2014 Q1	$73.7M	Hold	1,394,671	–	–	4.31%	9
2013 Q4	$55.9M	Buy	1,394,671 +727,800	+109%	+$28.7M	3.97%	10
2013 Q3	$25.2M	Buy	666,871 +149,371	+29%	+$5.83M	2.59%	20
2013 Q2	$20.3M	Buy	+517,500	New	+$20.2M	1.65%	31

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Holowesko Partners's TEVA Position: Q3 2014 in Review

Holowesko Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2014, closing a stake of 729,671 shares — an estimated $38.2M sold.

Holowesko Partners first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $73.7M in Q1 2014. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

Holowesko Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2014 after selling out during the quarter.
Holowesko Partners sold 729,671 Teva Pharmaceutical Industries Limited shares in Q3 2014, an estimated $38.2M.
Holowesko Partners first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 5 quarters.
Holowesko Partners's Teva Pharmaceutical Industries Limited position peaked at $73.7M in Q1 2014.
773 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2014.

Based on Holowesko Partners's 13F filing for Q3 2014, filed 10 Nov 2014.